SCHEMBL219293

SCHEMBL219293

CC([O])c1ccccc1Cl

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRB2 P07550 2/20 0.46
ADRB1 P08588 2/20 0.46
CYP3A4 P08684 2/20 0.45
CYP2D6 P10635 2/20 0.45
NFKB1 P19838 2/20 0.45
CYP1A2 P05177 1/20 0.45
PNMT P11086 1/20 0.45
NISCH Q9Y2I1 1/20 0.44
LMNA P02545 3/20 0.43
ALDH1A1 P00352 1/20 0.43
GLA P06280 1/20 0.43
TSHR P16473 3/20 0.43
ACP3 P15309 1/20 0.42
AOC3 Q16853 1/20 0.41
HIF1A Q16665 3/20 0.41
IDO1 P14902 2/20 0.41
TDO2 P48775 2/20 0.41
IDO2 Q6ZQW0 2/20 0.41
CYP2C19 P33261 2/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18378611 0.81 ADRB2 (0.43) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL13145151 0.80 P2RX7 (0.47) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL320794 0.80 P2RX7 (0.47) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL84509 0.79 GABRA1 (0.50) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL8651062 0.79 TSHR (0.47) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL12204154 0.79 ADRB2 (0.48) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL13145152 0.77 ADRB2 (0.47) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL1588934 0.77 ADRB2 (0.47) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL18730844 0.76 NISCH (0.55) ADRB2ADRB1CYP3A4CYP2D6NFKB1
SCHEMBL11617245 0.76 TSHR (0.50) ADRB2ADRB1CYP3A4CYP2D6NFKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 379 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2768307-B1 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS INC (US) 2020-03-18 EP disclosed
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical FUJIFILM WAKO PURE CHEMICAL CORPORATION (JP) 2019-10-22 US disclosed
EP-3100723-B1 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS INC (US) 2019-06-12 EP disclosed
EP-2785178-B1 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS INC (US) 2019-05-01 EP disclosed
US-20190023649-A1 Opsin-Binding Ligands, Compositions and Methods of Use BIKAM PHARMACEUTICALS, INC. (US) 2019-01-24 US disclosed
EP-2720539-B1 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS INC (US) 2018-10-24 EP disclosed
US-10040749-B2 Opsin-binding ligands, compositions and methods of use BIKAM PHARMACEUTICALS INC. (US) 2018-08-07 US disclosed
CN-103917093-B Opsin binding ligands, compositions, and methods of use 比卡姆药品公司 2017-08-11 CN disclosed
US-20170137398-A1 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE BIKAM PHARMACEUTICALS, INC. (US) 2017-05-18 US disclosed
CN-106431988-A Opsin-binding ligands, compositions and methods of use 比卡姆药品公司 2017-02-22 CN disclosed
EP-0222414-A2 Novel organic selenium compounds NIPPON KAYAKU KABUSHIKI KAISHA (JP) 1987-05-20 EP disclosed
WO-1986007059-A2 OXODIAZINE COMPOUNDS YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1986-12-04 WO disclosed
US-4423203-A Electrically photosensitive polymers containing vinylene-1,4-phenylene-imino-1,4-phenylene-vinylenearylene groups EASTMAN KODAK COMPANY (US) 1983-12-27 US disclosed
EP-0067217-A4 COMPOSITIONS OF POLYPHENYLENE OXIDES WITH EPDM-SILICONE RUBBER. GEN ELECTRIC (US) 1983-05-16 EP disclosed
EP-0067217-A1 COMPOSITIONS OF POLYPHENYLENE OXIDES WITH EPDM-SILICONE RUBBER GENERAL ELECTRIC COMPANY (US) 1982-12-22 EP disclosed
US-4365042-A Compositions of polyphenylene oxides with EPDM-silicone rubber GENERAL ELECTRIC COMPANY (US) 1982-12-21 US disclosed
WO-1982002204-A1 COMPOSITIONS OF POLYPHENYLENE OXIDES WITH EPDM-SILICONE RUBBER GEN ELECTRIC (US) 1982-07-08 WO disclosed
US-4304693-A Semisolid water-based coating compositions PPG INDUSTRIES, INC. (US) 1981-12-08 US disclosed
US-4174228-A SPRAYABLE FIREPROOFING MATERIAL PPG INDUSTRIES, INC. (US) 1979-11-13 US disclosed
US-4174229-A SPRAYABLE FIREPROOFING MATERIAL PPG INDUSTRIES, INC. (US) 1979-11-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170137398-A1 OPSIN-BINDING LIGANDS, COMPOSITIONS AND METHODS OF USE CRYAB, CRYAA, PDE6C ADRB2 1585/4885ADRB1 1222/4885CYP3A4 4427/4885
US-10451967-B2 Acid- and radical-generating agent and method for generating acid and radical CBR1, HAO2, CBR3 ADRB2 1222/4885ADRB1 967/4885CYP3A4 1029/4885
US-10040749-B2 Opsin-binding ligands, compositions and methods of use CRYAB, CRYAA, PDE6C ADRB2 1756/4885ADRB1 1383/4885CYP3A4 4496/4885
US-20190023649-A1 Opsin-Binding Ligands, Compositions and Methods of Use CRYAB, CRYAA, PDE6C ADRB2 1756/4885ADRB1 1383/4885CYP3A4 4496/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.